J. Moore

发表

Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection.

Anthony D Kelleher, Nitin K Saksena, John Moore, 2004, Blood.

T-cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists.

D. Ma, J. Moore, S. Carlin, 2013, Cytotherapy.

Profound thrombocytopenia related to G‐CSF

J. Rasko, J. Kovacic, R. Graham, 2007, American journal of hematology.

Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial.

J. Kovacic, R. Graham, M. Feneley, 2008, American heart journal.

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial.

T. Panzarella, G. Devins, Stephanie J. Lee, 2016, The Lancet. Oncology.

Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.

P. Macdonald, C. Hayward, A. Keogh, 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT)

I. Kerridge, N. Gilroy, J. Moore, 2016, Cancer medicine.

Endothelial progenitor cells, angioblasts, and angiogenesis--old terms reconsidered from a current perspective.

J. Kovacic, R. Graham, D. Ma, 2008, Trends in cardiovascular medicine.

What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia.

I. Kerridge, N. Gilroy, J. Moore, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning—do we need 200 mg/kg cyclophosphamide?

D. Ma, J. Moore, A. Carr, 2022, Bone Marrow Transplantation.

Autologous Hematopoietic Stem Cell Transplant for Systemic Sclerosis Improves Anemia from Gastric Antral Vascular Ectasia

M. Danta, D. Ma, J. Sahhar, 2015, Journal of Rheumatology.

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

M. Labopin, A. Gratwohl, J. Ouyang, 2010, Haematologica.

Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation

G. Lucchini, B. Sharrack, C. Hawkey, 2022, British journal of haematology.

Predictors of quality of life in allogeneic hematopoietic stem cell transplantation survivors

I. Kerridge, N. Gilroy, J. Moore, 2021, Journal of psychosocial oncology.

Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study.

I. Kerridge, N. Gilroy, J. Moore, 2020, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

A survey of infectious diseases and vaccination uptake in long‐term hematopoietic stem cell transplant survivors in Australia

I. Kerridge, N. Gilroy, J. Moore, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Changes to work status and household income of long-term allogeneic blood and marrow transplant survivors in New South Wales, Australia

I. Kerridge, N. Gilroy, J. Moore, 2018, Bone Marrow Transplantation.

A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia

I. Kerridge, N. Gilroy, J. Moore, 2016, British journal of haematology.

Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia

I. Kerridge, N. Gilroy, J. Moore, 2016, Supportive Care in Cancer.

Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia

Andrew K. Brown, Sarah L. Field, P. Emery, 2004, Arthritis research & therapy.

ABO-incompatible lung transplantation

R. Pierson, R. Merion, J. Moore, 2006 .

Stem cell transplantation for autoimmune diseases

P. Brooks, J. Moore, P. Brooks, 2009, Springer Seminars in Immunopathology.

Rheumatoid arthritis A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation

M. Handel, J. Moore, S. Milliken, 2004 .

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

L. Campbell, J. Szer, I. Lewis, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review

P. Richardson, J. Moore, G. McCaughan, 2022, British journal of haematology.

Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry‐based proteomics in an Australian cohort

P. Macdonald, C. Hayward, A. Dogan, 2020, Internal medicine journal.

Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis

J. Sierra, R. Martino, D. Ma, 2018, Bone Marrow Transplantation.

Early and late posttransplant lymphoproliferative disorder after lung transplantation--34 cases from the European PTLD Network.

H. Riess, V. Leblond, M. Dreyling, 2013, Transplantation.

A Phase 3 Double-Blind Study of the Addition of Tocilizumab versus Placebo to Cyclosporin/Methotrexate GvHD Prophylaxis.

S. Paul, G. Hill, K. Gartlan, 2021, Blood.

Diagnostic accuracy of SeptiFast multi-pathogen real-time PCR in the setting of suspected healthcare-associated bloodstream infection

G. Dunn, G. Warhurst, P. Dark, 2014, Intensive Care Medicine.

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial.

John Moore, Tania C Sorrell, T. Sorrell, 2013, The Lancet. Infectious diseases.

Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.

R. Herrmann, J. Szer, A. Schwarer, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant

D. Ma, I. Sutton, J. Moore, 2018, Front. Immunol..

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)

M. Sormani, J. D. de Vries-Bouwstra, B. Sharrack, 2019, Bone Marrow Transplantation.

Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis

R. Zivadinov, J. Zaunders, M. Barnett, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Stem cell transplantation in rheumatic diseases

P. Brooks, A. Tyndall, J. Moore, 2003 .

IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.

D. Cooper, A. Kelleher, M. Munier, 2010, Cytokine.

Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation

David D. F. Ma, I. Sutton, J. Moore, 2022, Frontiers in Immunology.

Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992–2005

J. Szer, D. Ma, J. Moore, 2011, Internal medicine journal.

Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004.

J. Simpson, J. Szer, D. Ma, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial

T. Panzarella, G. Devins, Stephanie J. Lee, 2014 .

I. Kerridge, D. Ma, W. Stevenson, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.

T. Panzarella, G. Devins, Stephanie J. Lee, 2020, The Lancet. Haematology.

A SYBR green‐based real‐time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients

Yi-Mo Deng, D. Ma, J. Moore, 2006, European journal of haematology.

A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.

P. Brooks, J. Snowden, G. McColl, 2002, Arthritis and rheumatism.

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases.

M. Labopin, J. Snowden, D. Farge, 2017, Blood advances.

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.

L. Campbell, J. Reynolds, J. Szer, 2015, The Lancet. Haematology.

Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.

P. Brooks, P. Emery, J. Snowden, 2004, The Journal of rheumatology.

Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse

J. Szer, I. Lewis, A. M. Johnston, 2018, Internal medicine journal.

Notch Signalling Inhibits CD4 Expression during Initiation and Differentiation of Human T Cell Lineage

D. Ma, J. Moore, S. Carlin, 2012, PloS one.

Sequential Blinatumomab with Reduced Intensity Chemotherapy in the Treatment of Older Adults with Newly Diagnosed Ph Negative B-Precursor Acute Lymphoblastic Leukemia - Interim Analysis of the Australasian Leukemia and Lymphoma Group ALL08 Study

A. Wei, S. Fleming, N. Venn, 2021, Blood.

Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases

D. Ma, J. Moore, M. Visweswaran, 2019, Bone Marrow Transplantation.

Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients With Human Immunodeficiency Virus (HIV)

S. Lewin, A. Kelleher, J. Zaunders, 2020, Clinical Infectious Diseases.

Altered immune reconstitution in HIV positive allogeneic stem cell transplant recipients.

S. Lewin, A. Kelleher, J. Zaunders, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis

E. Kotlyar, J. Moore, A. Jabbour, 2023, Journal of Scleroderma and Related Disorders.

Resolution of skin fibrosis and joint contractures in aggressive diffuse systemic sclerosis using autologous stem cell transplantation

A. Anandacoomarasamy, J. Moore, N. Manolios, 2006 .

Small-molecule inhibitor of glycogen synthase kinase 3β 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice.

N. Xu, A. Dolnikov, D. Ma, 2015, Stem cells and development.

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

J. Reynolds, J. Szer, C. Tiley, 2012, Blood.

Autologous haematopoietic stem cell therapy for multiple sclerosis: a review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation

B. Sharrack, J. Snowden, R. Saccardi, 2019, Current opinion in supportive and palliative care.

Integrated electronic health record facilitates a safer and more efficient rural outreach haematology service

J. Moore, S. Milliken, N. Hamad, 2020, Internal medicine journal.

Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey

I. Kerridge, N. Gilroy, J. Moore, 2021, Journal of Cancer Survivorship.

Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia

I. Kerridge, N. Gilroy, J. Moore, 2016, Cancer medicine.

Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction.

P. Tak, Malcolm D. Smith, H. Johnen, 2007, Arthritis and rheumatism.

Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Autoimmune Diseases: 10 Years Experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases

M. Labopin, A. Gratwohl, J. Ouyang, 2008 .

Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis

F. Luciani, R. Cheynier, J. Zaunders, 2022, Frontiers in Immunology.

All-trans-retinoic acid , idarubicin , and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia ( APML 4 )

J. Reynolds, J. Szer, C. Tiley, 2012 .

Gene profiling reveals association between altered Wnt signaling and loss of T-cell potential with age in human hematopoietic stem cells

Vivek Jayaswal, M. Lutherborrow, D. Ma, 2014, Aging cell.

Sustained immunotolerance in multiple sclerosis after stem cell transplant

J. Zaunders, I. Sutton, J. Moore, 2022, Annals of clinical and translational neurology.

Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis

D. Ma, I. Sutton, J. Moore, 2021, Multiple sclerosis.

Rituximab and its potential for the treatment of rheumatoid arthritis

J. Moore, A. Bryant, 2006, Therapeutics and clinical risk management.

therapy in acute promyelocytic leukemia (APML4) -retinoic acid, idarubicin, and IV arsenic trioxide as initial trans All-

J. Reynolds, J. Szer, C. Tiley, 2013 .

Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: a placebo controlled crossover trial

J. Kovacic, R. Graham, M. Feneley, 2011, Heart.

Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study

I. Kerridge, C. Tiley, S. Harrison, 2020 .

Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres

S. Ling, J. Moore, A. Bryant, 2020, Bone Marrow Transplantation.

Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?

I. Kerridge, N. Gilroy, J. Moore, 2017, Supportive Care in Cancer.

Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis.

I. Sutton, J. Moore, M. Visweswaran, 2023, Clinical immunology.

The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia

I. Kerridge, N. Gilroy, J. Moore, 2016, Bone Marrow Transplantation.

CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry

W. Sewell, J. Moore, A. Dodds, 2018, International journal of laboratory hematology.

Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey

N. Gilroy, J. Moore, I. Kerridge, 2023, BMC Psychology.

Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study

J. Moore, A. Bajel, A. Solterbeck, 2023, Blood Advances.

Oral health and dental morbidity in long‐term allogeneic blood and marrow transplant survivors in Australia

I. Kerridge, N. Gilroy, J. Moore, 2018, Australian dental journal.

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial.

T. Sorrell, J. Szer, A. Schwarer, 2013, The Lancet. Infectious diseases.

Recurrent secondary graft failure likely due to a DRB4 donor-specific antibody in a patient with aplastic anemia and DRB4 null allele

J. Moore, Jock D Simpson, L. Weston, 2021, Bone Marrow Transplantation.

A phase II study of risk‐adapted intravenous melphalan in patients with AL amyloidosis

S. Paul, C. Tiley, H. Prince, 2012, British journal of haematology.

IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.

D. Cooper, A. Kelleher, M. Munier, 2010, Cytokine.

Long‐term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis

W. Stevenson, J. Moore, I. Kerridge, 2023, Internal medicine journal.

Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional Survey

N. Gilroy, J. Moore, I. Kerridge, 2023, Clinical nursing research.